Tuesday, July 03, 2012 3:21:39 AM
Leiden, The Netherlands, July 03, 2012. Biotech company Pharming Group NV (“Pharming” or “the Company”) (NYSE Euronext: PHARM) announced today that it had signed an agreement to sell the tangible assets of its US operations. Following the announcement of the closure of the US based cattle platform research operations, a swift process has lead to the sale of the tangible assets; the farm buildings and surrounding land in Wisconsin, to Sexing Technologies, a private company based in Navasota, Texas. Sexing Technologies Inc. specializes in the genetic improvement and reproductive services and export of livestock, primarily through the production and commercialization of sexed sorted semen and embryos, around the globe (http://www.sexingtechnologies.com/). Please refer to our press release of 25 June 2012 for more deta ils on the closing of the US based research facilities.
Further discussions concerning the sale of some of the legacy projects that were primarily located in the US operation are ongoing.
Recent PHARM News
- Pharming Group to participate in September investor conferences • GlobeNewswire Inc. • 09/04/2024 05:00:00 AM
- Pharming Group reports second quarter and first half 2024 financial results and provides business update • GlobeNewswire Inc. • 08/01/2024 05:00:00 AM
- Pharming Group to report second quarter and first half 2024 financial results on August 1 • GlobeNewswire Inc. • 07/18/2024 06:00:00 AM
- Pharming Group to participate in June investor conferences • GlobeNewswire Inc. • 06/03/2024 06:00:00 AM
- Pharming Group to participate in June investor conferences • GlobeNewswire Inc. • 06/03/2024 06:00:00 AM
- Pharming Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union • GlobeNewswire Inc. • 05/30/2024 08:44:24 PM
- Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders • GlobeNewswire Inc. • 05/21/2024 03:30:14 PM
- Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders • GlobeNewswire Inc. • 05/21/2024 03:30:14 PM
- Pharming Group to participate in May investor conference • GlobeNewswire Inc. • 05/20/2024 06:00:00 AM
- Pharming Group to participate in May investor conference • GlobeNewswire Inc. • 05/20/2024 06:00:00 AM
- Pharming Group announces the early redemption of the remaining outstanding €125 million convertible bonds due 2025 • GlobeNewswire Inc. • 05/15/2024 05:00:00 AM
- Pharming Group reports first quarter 2024 financial results and provides business update • GlobeNewswire Inc. • 05/08/2024 05:00:00 AM
- Pharming Group reports first quarter 2024 financial results and provides business update • GlobeNewswire Inc. • 05/08/2024 05:00:00 AM
- Pharming Group to report first quarter 2024 financial results on May 8 • GlobeNewswire Inc. • 04/24/2024 06:00:00 AM
- Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards • GlobeNewswire Inc. • 04/24/2024 05:00:00 AM
- Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards • GlobeNewswire Inc. • 04/24/2024 05:00:00 AM
- Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025 • GlobeNewswire Inc. • 04/19/2024 04:43:36 PM
- Pharming Group announces the placement of €100 million convertible bonds due 2029 • GlobeNewswire Inc. • 04/18/2024 01:04:30 PM
- Pharming Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025 • GlobeNewswire Inc. • 04/18/2024 06:00:00 AM
- Pharming announces completion of enrollment in pediatric clinical trial of leniolisib • GlobeNewswire Inc. • 04/08/2024 05:00:00 AM
- Pharming announces completion of enrollment in pediatric clinical trial of leniolisib • GlobeNewswire Inc. • 04/08/2024 05:00:00 AM
- Pharming Group announces the 2024 Annual General Meeting of Shareholders • GlobeNewswire Inc. • 04/04/2024 06:30:00 AM
- Pharming Group announces the filing of its 2023 Annual Report and Form 20-F • GlobeNewswire Inc. • 04/04/2024 05:00:00 AM
- Pharming Group to participate in April investor conferences • GlobeNewswire Inc. • 04/03/2024 06:00:00 AM
- Pharming Group to participate in April investor conferences • GlobeNewswire Inc. • 04/03/2024 06:00:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM